A team at Rice University is designing wearable technology that can be used for navigation for users with visual and auditory impairments. Photo by Brandon Martin/Rice University

A group of Rice researchers have tapped into the sense of touch to improve how wearable technology can communicate with its user.

Barclay Jumet, a mechanical engineering PhD student at Rice working in the labs of Daniel Preston and Marcia O’Malley, published the findings in the August issue of “Device.” The study outlines the group's new system of haptic accessories that rely heavily on fluidic control over electrical inputs to signal or simulate touch to a wearer. The research was supported by the National Science Foundation, the Rice University Academy of Fellows, and the Gates Millennium Scholars Program.

The accessories include a belt and textile sleeves, which deliver haptic cues like vibration, tapping and squeezing through pressure generated by a lightweight carbon dioxide tank attached to the belt. The sleeve contains up to six quarter-sized pouches that inflate with varying force and frequency, depending on what is being communicated to the wearer.

Marcia O'Malley (from left), Barclay Jumet and Daniel Preston developed a wearable textile device that can deliver complex haptic cues in real time to users on the go. Photo by Brandon Martin/Rice University

The team says the wearables have uses for those with visual and auditory impairments and offer a slimmed-down design compared to other bulky complex haptic wearables. The wearables are also washable and repairable, which gives them more everyday uses.

To test the system's usability, the team guided a user on a mile-long route through Houston, signaling haptic cues for forward, backward, left or right through the devices.

“In the future, this technology could be directly integrated with navigational systems, so that the very textiles making up one’s clothing can tell users which way to go without taxing their already overloaded visual and auditory senses—for instance by needing to consult a map or listen to a virtual assistant,” Jumet said in a release from Rice.

O’Malley, chair of the Department of Mechanical Engineering, said the system could also work in tandem with Cochlear implants and make lip-reading easier for users in noisy environments by directing users to sources of sound.

Jumet also sees uses outside of the medical space.

“Instead of a smart watch with simple vibrational cues, we can now envision a ‘smart shirt’ that gives the sensation of a stroking hand or a soft tap on the torso or arm,” he said in the release. “Movies, games and other forms of entertainment could now incorporate the sense of touch, and virtual reality can be more comfortable for longer periods of time.”


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.